Article
Prevention of neointimal hyperplasia after coronary artery bypass graft via local delivery of sirolimus and rosuvastatin: network pharmacology and in vivo validation
2023-10-09
Abstract excerpt
<h4>Background: </h4> Coronary artery bypass graft (CABG) is generally used to treat complex coronary artery disease. Treatment success is affected by neointimal hyperplasia (NIH) of graft and anastomotic sites. Although sirolimus and rosuvastatin individually inhibit NIH progression, the efficacy of combination treatment remains unknown. Methods We identified cross-targets associated with CABG, sirolimus, and ro...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b0da3ef0-077d-5da9-bd5e-f012583cc292
- DOI
- 10.21203/rs.3.rs-3344075/v1
